Jiangsu Tiera Biotechnology Co., Ltd. was established in 2016, and currently has 5 years of expertise in the industry of aesthetic products with nearly 100 employees.
was established in 2016, and currently has 5 years of expertise in the industry of aesthetic products with nearly 100 employees. The production base covers an area of 20,000 square meters, with 2 GMP purification workshops of 2,000 square meters, and a R&D center and a quality inspection center of 1,000 square meters.
Tiera Biotechnology has always put quality at the first place. High-precision analytical instruments like GC, GCMS, TA rheometer, Malvern particle size analyzer are used by our skilled staff to carry out tests for incoming and outgoing quality control. Meanwhile, Tiera has a strong research and development team with more than 20 experienced engineers. Each year, over 2.3 million dollars is invested into R&D to create pioneering aesthetic products.
Development of History
Jiangsu Tiera Biotechnology Co.,Ltd
In 2021,
2021 Passed Anvisa GMP certification. And obtained Russian Medical Registration Certificate.
In 2020,
2020 Get MDSAP certified. The company actively paticipates in the on-line international marketing. Invested in R&D of new aesthetic products.
In 2019,
2019 Get ISO13485 certified and Started the Medical registration in Russia and Brazil. Established good relation with clients all over the world.
In 2018,
2018 Passed the biological compatible testing of cross-linked hyaluronic acid dermal fillers. The CFDA registration process started. Attend Dubai Derma in Dubai and Intercharm exhibition in Moscow for the 1st time.
In 2017,
2017 Finished the construction of the production building and installation of the clean room with an area of 5000㎡.
In 2016,
2016 Established Jiangsu Tiera Biotechnology Co., Ltd.
Tiera has a strong research and development team with more than 20 experienced engineers. Each year, over 2.3 million dollars is invested into R&D to create pioneering aesthetic products.We will continue to uphold the principle of quality first and customer first, continue to develop better and safer products, and contribute more to the progress and development of the medical aesthetics industry.
English
